| Literature DB >> 31523685 |
Yong-Gon Seo1, Jidong Sung2, Mal-Soon Shin3, Yun-Jin Park3, Kyoung-Bin Min3, Gyu-Min Kang3, Jong-Min Lee4, Myung-Ki Kim3.
Abstract
There is a lack of evidence on the effect of exercise-based cardiac rehabilitation (EBCR) in patients treated with total thoracoscopic ablation (TTA) for atrial fibrillation (AF). Our study investigated the efficacy and safety of postoperative exercise intervention in patients recovering from TTA. Twenty-four patients participated in the study, and were divided into the two groups, exercise group (EG) (n=12) and control group (n= 12). Patients in EG performed the exercise intervention including the aerobic and resistance exercise program twice a week for 8 weeks, which was used as a hospital-based cardiac rehabilitation for the out-patient. A cardiopulmonary exercise test was administered to evaluate aerobic exercise capacity, and qualitative aspect of patient's life was assessed using the Short Form 36 questionnaires to compare pre and postoperative wellness of patient's life. Although there was an increase of VO2peak (peak oxygen uptake) after exercise intervention, no significant improvement was found (P=0.055). Two of 4 physical health scores (role-physical, P=0.013 and general health, P=0.05) and three of four mental health scores (vitality, P=0.027, social function, P=0.016, and mental health, P=0.003) were significantly improved after 8 weeks of EBCR. Each summarized scale in the physical (P=0.022) and mental (P= 0.004) survey section was also significantly improved in postoperative assessment compared to the preoperative one. In this context, we concluded that EBCR initiated at the time point of 4th week after TTA operation can guarantee the secure postoperative physical activity, and the 8 weeks of EBCR can effectively improve the quality of life in AF Patients.Entities:
Keywords: Atrial fibrillation; Cardiac rehabilitation; Quality of life
Year: 2019 PMID: 31523685 PMCID: PMC6732541 DOI: 10.12965/jer.1938340.170
Source DB: PubMed Journal: J Exerc Rehabil ISSN: 2288-176X
Samsung modified Bruce protocol
| Stage | Speed (mph) | Grade (%) | Time (min) |
|---|---|---|---|
| Rest/recovery | 1.2 | 0 | 0 |
| 1 | 1.7 | 0 | 3 |
| 2 | 1.7 | 5 | 3 |
| 3 | 1.7 | 10 | 3 |
| 4 | 2.5 | 12 | 3 |
| 5 | 3.4 | 14 | 3 |
| 6 | 4.2 | 16 | 3 |
| 7 | 5.0 | 18 | 3 |
| 8 | 5.5 | 20 | 3 |
| 9 | 6.0 | 22 | 3 |
Baseline characteristics of the subjects
| Characteristic | EG (n=12) | CG (n=12) |
|---|---|---|
| Age (yr) | 58.4±6.5 | 59.5±6.1 |
|
| ||
| Height (cm) | 168.4±4.5 | 168.8±7.5 |
|
| ||
| Weight (kg) | 73.8±9.6 | 72.5±9.5 |
|
| ||
| Type of AF | ||
| Paroxysmal | 4 (33) | 4 (33) |
| Persistent | 8 (67) | 8 (67) |
|
| ||
| Concomitant disease | ||
| Hypertension | 3 (25) | 6 (50) |
| Diabetes mellitus | 1 (8) | 0 (0) |
| Dyslipidemia | 4 (33) | 2 (17) |
| Ischemic heart disease | 1 (8) | 0 (0) |
| Dilated cardiomyopathy | 1 (8) | 2 (17) |
| Stroke | 1 (8) | 0 (0) |
|
| ||
| Previous intervention | ||
| Cardioversion | 6 (50) | 5 (42) |
| Ablation | 2 (17) | 1 (8) |
|
| ||
| Medication treatment | ||
| Antiarrhythmic drug | 8 (67) | 9 (75) |
| Beta-blocker | 4 (33) | 4 (33) |
| Angiotensin II receptor blocker | 4 (33) | 3 (25) |
| ACE-inhibitor | 1 (8) | 0 (0) |
| Digoxin | 1 (8) | 0 (0) |
| Dabigatran | 1 (8) | 3 (25) |
| Warfarin | 3 (25) | 1 (8) |
| Statin | 1 (8) | 2 (17) |
| NOAC | 7 (58) | 5 (42) |
Values are presented as mean±standard deviation or number (%).
EG, exercise group; CG, control group; AF, atrial fibrillation; ACE, angiotensin converting enzyme; NOAC, new oral anticoagulant.
Result of physical health at preoperatively and 3 months postoperatively
| Variable | Exercise group | Control group | ||||
|---|---|---|---|---|---|---|
|
|
| |||||
| Baseline | 3 Months | Baseline | 3 Months | |||
| VO2peak | 26.91±7.18 | 28.89±7.63 | 28.31±7.44 | 26.85±6.23 | 4.12 | 0.055 |
|
| ||||||
| Physical function | 82.91±16.84 | 89.16±16.21 | 87.08±4.05 | 87.92±19.12 | 2.04 | 0.167 |
|
| ||||||
| Role-physical | 71.89±24.0 | 86.98±22.03 | 81.85±7.56 | 83.85±20.89 | 7.28 | 0.013 |
|
| ||||||
| Bodily pain | 77.92±18.73 | 86.45±15.65 | 82.91±7.35 | 88.33±14.63 | 0.39 | 0.537 |
|
| ||||||
| General health | 60.83±26.27 | 72.08±22.81 | 64.58±5.44 | 66.67±15.28 | 4.30 | 0.050 |
|
| ||||||
| PCS | 67.77±22.11 | 83.16±17.75 | 79.10±3.15 | 81.69±15.56 | 6.11 | 0.022 |
Values are presented as mean±standard deviation.
VO2peak, peak oxygen uptake; PCS, physical component scores.
F-value and P-value mean the result of interaction between group and time from two-way repeated analysis of variance.
P<0.05.
P<0.001.
Significant difference within group confirmed by paired t-test.
Result of mental health at preoperatively and 3 months postoperatively
| Variable | Exercise group | Control group | ||||
|---|---|---|---|---|---|---|
|
|
| |||||
| Baseline | 3 Months | Baseline | 3 Months | |||
| Vitality | 54.98±25.29 | 65.90±16.38 | 64.62±11.71 | 59.38±13.98 | 5.64 | 0.027 |
|
| ||||||
| Social function | 75.00±22.61 | 89.58±15.84 | 84.38±6.96 | 83.33±22.19 | 6.74 | 0.016 |
|
| ||||||
| Role-emotional | 81.94±24.32 | 95.83±8.34 | 84.03±9.93 | 88.89±18.23 | 2.17 | 0.155 |
|
| ||||||
| Mental health | 67.77±22.11 | 83.16±17.75 | 71.67±16.28 | 66.25±15.83 | 10.98 | 0.003 |
|
| ||||||
| MCS | 67.77±22.11 | 81.02±11.18 | 75.76±14.68 | 74.46±14.90 | 10.08 | 0.004 |
Values are presented as mean±standard deviation.
MCS, mental component scores.
F-value and P-value mean the result of interaction between group and time from two-way repeated analysis of variance.
P<0.05.
P<0.01.
Significant difference within group confirmed by paired t-test.